Results 31 to 40 of about 28,157 (212)
Safety and efficacy of RNA vaccines: State of the art
Медицинская иммунология, 2021 This review describes principles of action and the method of delivery of mRNA molecules into cells, as well as some of developed RNA vaccines and the results obtained in their study, though they have not been authorized for use yet.
A. V. Blagov +3 more
doaj +1 more source
Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Human Vaccines & Immunotherapeutics, 2023 This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women.
Chenchit Chayachinda +16 more
doaj +1 more source
Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
Case Reports in Ophthalmology, 2022 Two days after the second dose of the messenger RNA-based COVID-19 vaccine (BNT162b2), a healthy 38-year-old man developed branch retinal vein occlusion (BRVO) in his left eye (OS).
Kazunobu Sugihara +2 more
doaj +1 more source
Is a single COVID-19 vaccine dose enough in convalescents ?
Human Vaccines & Immunotherapeutics, 2021 SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses.
Daniele Focosi +2 more
doaj +1 more source
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Avicenna Journal of Medicine, 2022 Background Currently, the most effective method in the fight against coronavirus disease 2019 (COVID-19) is vaccination against the disease. However, there are hesitations among society concerning the safety and side effects of COVID-19 vaccines.
Erdal Yavuz +6 more
doaj +1 more source
Reproductive BioMedicine Online, 2022 Do elective oocyte cryopreservation outcomes in women 1-13 months after SARS-CoV-2 vaccination alter compared with unvaccinated women and do different time intervals between vaccination and ovarian stimulation impact these outcomes?This retrospective cohort study, conducted in a university-affiliated IVF centre, included 232 elective oocyte ...
Gilad Karavani +7 more
openaire +2 more sources
Nature Communications, 2022 Abstract Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19, ChAd) followed by an mRNA vaccine (e.g. BNT162b2, BNT) has been reported to be superior in inducing protective immunity compared to repeated application of the same vaccine.
Georg M. N. Behrens +27 more
openaire +4 more sources
Waning Immunity after the BNT162b2 Vaccine in Israel
New England Journal of Medicine, 2021 In December 2020, Israel began a mass vaccination campaign against coronavirus disease 2019 (Covid-19) by administering the BNT162b2 vaccine, which led to a sharp curtailing of the outbreak. After a period with almost no cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a resurgent Covid-19 outbreak began in mid-June 2021.
Yair Goldberg +9 more
openaire +2 more sources
Eosinophilic cellulitis after BNT162b2 mRNA Covid‐19 vaccine [PDF]
Journal of the European Academy of Dermatology and Venereology, 2021 A 71-year-old woman with history of treated high blood pressure and atrial fibrillation presented with a painful eruption of the right arm and forearm. Symptoms started the day following the second dose of the BNT162b2 COVID-19 vaccine (Pfizer/BioNTech) with a localized injection site reaction that progressively worsened.
L. de Montjoye, L. Marot, M. Baeck
openaire +3 more sources
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
Infection and Drug Resistance, 2022 Naif Khalaf Alharbi,1,2 Jaffar A Al-Tawfiq,3– 5 Amal Alwehaibe,1 Mohamed W Alenazi,1 Abdulrahman Almasoud,1 Abdullah Algaisi,6 Fahad A Alhumaydhi,7 Anwar M Hashem,8,9 Mohammed Bosaeed,1,2,10 Suliman A Alsagaby11 1Vaccine Development Unit, King Abdullah ...
Alharbi NK +9 more
doaj